Syneos Health

$68.46 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Syneos Health

Syneos Health Inc. is a fully integrated biopharmaceutical solutions providing company. The Company offers both stand-alone and integrated biopharmaceutical product development solutions through its Contract Research Organization (CRO) and Contract Commercial Organization (CCO), ranging from Early Phase (Phase I) clinical trials to the full commercialization of biopharmaceutical products. It brings together approximately 24,000 clinical and commercial professionals with the ability to support customers in more than 110 countries. Together it shares insights, leverages latest technologies and apply advanced business practices to deliver important therapies to patients.

Stock Analysis

last close $67.96
1-mo return -7.2%
3-mo return -7.9%
avg daily vol. 690.59T
52-week high 104.18
52-week low 62.28
market cap. $7.0B
forward pe 13.2
annual div. -
roe 8.5%
ltg forecast 11.9%
dividend yield -
annual rev. $5.4B
inst own. 98.9%

Subscribe now for daily local and international financial news